Efficacy and Safety of Recombinant Human Thrombopoietin (rhTPO) on Coagulation Function and Inflammatory Factors in the Treatment of Patients with Sepsis-Related Thrombocytopenia
Background this study aimed to investigate the efficacy of recombinant human thrombopoietin (rhTPO) in the treatment of sepsis-associated thrombocytopenia, and to evaluate its impact on coagulation function, inflammatory markers, platelet (Plt) count, and patient prognosis. Methods a total of 144 pa...
Saved in:
Main Authors: | Huijuan Wang MD, Dong Chen MD, Ming He MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296251315173 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors
by: Huan Hu, et al.
Published: (2025-01-01) -
Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
by: Ke Zhang, et al.
Published: (2018-01-01) -
Letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Matthew K. Wun
Published: (2025-01-01) -
Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01) -
Response to letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Marjory B. Brooks, et al.
Published: (2025-01-01)